IBAT inhibitors for the treatment of liver diseases
US10981952B2 · kind B2 · utility
16Cited by
54References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2020 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Jan 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.